MET and adenocarcinoma: Lung puncture pathology suggested adenocarcinoma with MET exon 14 mutation (exon14, c.2888-1G>C) and TP53 mutation (exon2,c.241C>T,p.R81X), PD-L1 tumor proportion score (TPS) 18.34%.